The PREDI-LYNCH project

Toni Seppälä, Jussi Nikkola, Piia Takabe
Jan 1, 2026
Official Website

The PREDI-LYNCH project is dedicated to advancing early detection and personalized prevention of Lynch syndrome, a hereditary condition that predisposes individuals to colorectal, endometrial, and several other types of cancer.

Through collaboration with leading medical institutions and researchers, the project aims to refine risk assessment tools that combine genetic markers, family history, and lifestyle factors. This holistic approach enables healthcare providers to offer tailored screening and prevention strategies, ultimately reducing cancer incidence and improving long-term patient outcomes.

PREDI-LYNCH also emphasizes patient education and accessibility, ensuring that risk prediction tools are user-friendly and available to diverse populations. By bridging the gap between research and clinical practice, the PREDI-LYNCH project strives to empower individuals and clinicians alike with actionable insights for precision medicine in hereditary cancer prevention.

  • Duration: 2025–2031
  • Role: Leader of clinical studies
EU Project Lynch Syndrome Hereditary Cancer Precision Medicine
Co-funded by the European Union

Core Team

Toni Seppälä
Jussi Nikkola
Piia Takabe